We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$342M
AUM Growth
+$13M
Cap. Flow
-$5.62M
Cap. Flow %
-1.64%
Top 10 Hldgs %
35.71%
Holding
394
New
46
Increased
49
Reduced
94
Closed
31
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
26
McCormick & Company Non-Voting
MKC
$14.9B
$4.13M 1.2%
42,502
-180
-0.4% -$17.6K
MO icon
27
Altria Group
MO
$115B
$3.52M 1.03%
91,103
+1,101
+1% +$45.8K
FNV icon
28
Franco-Nevada
FNV
$51.3B
$3.43M 1%
24,577
+986
+4% +$146K
WY icon
29
Weyerhaeuser
WY
$17B
$3.42M 1%
119,865
-2,220
-2% -$61K
SYK icon
30
Stryker
SYK
$127B
$3.23M 0.94%
15,485
-470
-3% -$91.4K
PM icon
31
Philip Morris
PM
$299B
$3.22M 0.94%
42,910
-305
-0.7% -$23.5K
KO icon
32
Coca-Cola
KO
$386B
$3.19M 0.93%
64,661
XSLV icon
33
Invesco S&P SmallCap Low Volatility ETF
XSLV
$245M
$2.96M 0.87%
89,278
-665
-0.7% -$22.9K
TFX icon
34
Teleflex
TFX
$5.92B
$2.9M 0.85%
8,515
-235
-3% -$87K
HCI icon
35
HCI Group
HCI
$2.32B
$2.71M 0.79%
54,975
ADP icon
36
Automatic Data Processing
ADP
$114B
$2.53M 0.74%
18,124
-685
-4% -$96K
EL icon
37
Estee Lauder
EL
$37.4B
$2.52M 0.74%
11,565
SYBT icon
38
Stock Yards Bancorp
SYBT
$2.48B
$2.43M 0.71%
71,361
-75
-0.1% -$3K
RMD icon
39
ResMed
RMD
$34.7B
$2.35M 0.69%
13,712
-130
-0.9% -$24K
TRP icon
40
TC Energy
TRP
$64.4B
$2.09M 0.61%
49,804
-500
-1% -$22.9K
EW icon
41
Edwards Lifesciences
EW
$52B
$2.08M 0.61%
26,082
USB.PRM
42
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$2.04M 0.6%
76,510
-500
-0.6% -$13.4K
ROP icon
43
Roper Technologies
ROP
$42.2B
$2.03M 0.59%
5,137
TD icon
44
Toronto Dominion Bank
TD
$199B
$2.03M 0.59%
43,904
-200
-0.5% -$9.31K
MRK icon
45
Merck
MRK
$366B
$1.96M 0.57%
24,817
-356
-1% -$27.9K
BIIB icon
46
Biogen
BIIB
$32.3B
$1.96M 0.57%
6,891
-39
-0.6% -$10.9K
GOOG icon
47
Alphabet (Google) Class C
GOOG
$4.19T
$1.86M 0.54%
25,300
+1,400
+6% +$107K
NVO
48
Novo Nordisk
NVO
$202B
$1.78M 0.52%
51,386
-400
-0.8% -$13.3K
BRK.B icon
49
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.67M 0.49%
7,824
-80
-1% -$16.4K
HIFS icon
50
Hingham Institution for Saving
HIFS
$650M
$1.65M 0.48%
8,963
-12
-0.1% -$2.19K

Similar funds

American Research & Management Company's Q3 2020 Portfolio in Review

As of Q3 2020, American Research & Management Company held 394 positions worth $342M, up 3.9% from $329M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

American Research & Management Company's Q3 2020 filing shows 46 new, 49 increased, 94 reduced and 31 closed positions. Its largest new stake was Service Corp International: 2,450 shares worth $103K. The largest sale was Vertex Pharmaceuticals, an estimated $2.87M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • American Research & Management Company's largest Q3 2020 buy was Service Corp International: 2,450 shares worth $103K.
  • American Research & Management Company added most to Alerian MLP ETF in Q3 2020, an estimated $6.58M increase.
  • American Research & Management Company's biggest Q3 2020 reduction was NVIDIA, cutting an estimated $1.08M.
  • American Research & Management Company fully exited Vertex Pharmaceuticals in Q3 2020, selling an estimated $2.87M.
  • American Research & Management Company's ten largest holdings make up 36% of its $342M portfolio in Q3 2020.
  • American Research & Management Company opened 46 new positions and closed 31 in Q3 2020.
  • American Research & Management Company's portfolio value rose 3.9% quarter-over-quarter to $342M.

Based on American Research & Management Company's 13F filing for Q3 2020, filed 29 Oct 2020.